GALT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Galectin Therapeutics Inc (GALT) is not a good buy for a beginner, long-term investor at this time. The stock shows weak financial performance, bearish technical indicators, and no significant positive catalysts or trading signals to support an immediate investment decision.
The stock exhibits bearish technical indicators. The MACD is negatively expanding below zero, RSI is neutral at 36.917, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support levels are at 2.225 and 2.086, with resistance at 2.676 and 2.815. The stock is trading below its pivot level of 2.45, indicating downward momentum.
NULL identified. No recent news, no significant insider or hedge fund activity, and no recent congress trading data.
The stock has dropped 11.72% during regular market hours, and financial performance is weak with declining net income (-53.77% YoY) and EPS (-52.63% YoY). Technical indicators and trading trends are bearish or neutral.
In 2025/Q4, the company reported no revenue growth (0% YoY), a significant drop in net income to -$5.56 million (-53.77% YoY), and a decline in EPS to -0.09 (-52.63% YoY). Gross margin remains at 0%.
No recent analyst rating or price target changes available.
